Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2007
View Archived Issues
Motavizumab safe in children treated for a second respiratory syncytial virus season
Read More
Diindolylmethane a possible alternative to surgery for cervical dysplasia
Read More
Increased CSF levels of NGF and BDNF detected in patients with migraine or PFMS
Read More
Rights to civamide acquired by OPKO Health
Read More
NIAID expands Imvamune smallpox vaccine trials in persons with atopic dermatitis
Read More
Ariad and Icon codevelop deforolimus-eluding stents
Read More
Maas Biolab awarded NIH grant to develop intrathecal ciclosporin
Read More
Amarillo Biosciences issues update on clinical trials
Read More
Novel agents for musculoskeletal and connective tissue disorders disclosed in recent patents
Read More
Alpharma to license U.S. rights for topical NSAID pain drug
Read More
Covidien and BioSynthema sign agreement for nuclear medicine cancer therapy
Read More
Results for BDM-E phase I/II clinical trial
Read More
Positive phase IIa clinical study results for MN-221 in status asthmaticus
Read More
Hisamitsu reports results of phase III HFT-290 trial
Read More
Nile reports positive phase I results for CD-NP in heart failure
Read More
Masitinib mesylate safe and effective in indolent systemic mastocytosis
Read More
Preclinical safety study of GSAO, a potential anticancer compound
Read More
Pozen responds to FDA approvable letter for Trexima
Read More
The FDA extends regulatory review period for Tysabri for Crohn's disease
Read More
Hycamtin approved for treatment of relapsed small cell lung cancer
Read More
Partial hold on clinical development of Telcyta removed
Read More
FDA approves Ixempra for the treatment of advanced breast cancer
Read More
Recent AstraZeneca patent describes novel therapeutic agents for respiratory disorders
Read More
New agents for treating HIV infection reported in recent Trimeris patent
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe